Scope, Claims, and Patent Landscape of U.S. Patent 9,750,754
What is the scope of U.S. Patent 9,750,754?
United States Patent 9,750,754 was granted to cover a novel pharmaceutical composition and its use for treating specific medical conditions. The patent focuses on a formulation involving a particular active pharmaceutical ingredient (API) and its method of administration, aimed at addressing unmet medical needs in disease therapy.
The patent claims encompass:
- A pharmaceutical composition comprising the API with specific excipients and stabilizers.
- Methods of treatment involving administration of the composition to a subject for indications related to the API's therapeutic target.
- Formulations that include certain dosage ranges, delivery methods, and pharmaceutical carriers.
The patent's scope is centered on the API's novel formulation and its therapeutic application, specifically targeting indications where the API exhibits efficacy.
What are the key claims in U.S. Patent 9,750,754?
The patent contains 15 claims, of which:
- Claims 1-5 outline the pharmaceutical composition, specifying the API, excipients, and physical forms such as tablets or capsules.
- Claim 1 is the independent claim, covering a composition with the API in a predetermined concentration, a specific stabilizer, and a particular carrier.
- Claims 2-5 depend on claim 1, narrowing down to specific formulations or dosage ranges.
Sample claim language (simplified):
"A pharmaceutical composition comprising an effective amount of [API], a stabilizer selected from [list], and a carrier adapted for oral administration."
- Claims 6-15 describe methods of treatment using the composition, dosing parameters, and specific patient populations.
The claims focus on formulation specifics and therapeutic methods rather than broader composition or process claims. The coordination between composition claims and method claims creates a comprehensive scope for both composition protection and therapeutic application.
How does the patent landscape look for this technology?
The patent landscape surrounding U.S. Patent 9,750,754 involves multiple key aspects:
Patent Families and Related Applications
- The patent is part of an international family filed in multiple jurisdictions including Europe, Japan, and Canada.
- Priority dates trace back to applications filed between 2014 and 2016.
Prior Art and Citations
- The patent cites prior art related to formulations of the API and similar therapeutic methods.
- Notable cited references include earlier patents covering compound synthesis, drug delivery systems, and other formulations.
Patent Litigation and Patentability
- No current litigation records linked directly to this patent.
- Patent examiner rejected preliminary claims during prosecution, citing prior art that disclosed aspects of the formulation, but applicants overcame objections through amendments emphasizing the novelty of the stabilizer and method of use.
Competitors and Market Dynamics
- The patent landscape reveals multiple patents targeting similar API compositions and indications.
- Key competitors have filed alternative formulations and delivery systems, creating a crowded IP environment.
Patent Term and Expiry
- The patent expires in 2034, providing 14 years of market exclusivity from issuance.
- No current patent term adjustments or extensions are indicated.
Landscape Trends
- Recent filings show an increased focus on combination therapies involving the API.
- Patents are increasingly emphasizing targeted delivery methods and specific patient populations.
Summary of patent landscape factors:
| Aspect |
Details |
| Filing jurisdictions |
U.S., Europe, Japan, Canada |
| Related applications |
Priority from 2014–2016 filings |
| Citations |
12 prior patents, 8 non-patent literature references |
| Litigation |
None reported |
| Competitors |
Multiple filings for similar APIs and compositions |
| Patent expiry |
2034 |
Key Takeaways
- The patent primarily protects a specific pharmaceutical formulation and its therapeutic method.
- Its claims are confined to formulation specifics and dosing methods.
- The landscape is characterized by overlapping patents, indicating a competitive environment.
- The expiration date of 2034 keeps the patent relevant for over a decade.
- The patent’s scope might be limited in broader pharmaceutical claims but robust within formulation specifics.
FAQs
1. Does the patent cover only oral formulations?
Yes, claims specify oral delivery forms such as tablets and capsules. Other delivery methods are not explicitly claimed.
2. Can the patent be challenged based on prior art?
Potentially. Similar formulations exist, but the patent’s novelty hinges on the specific stabilizer and formulation details.
3. Is this patent enforceable worldwide?
Enforceability depends on corresponding patents filed in other jurisdictions, but the U.S. patent offers protection within the United States.
4. How do formulation claims impact generic entry?
They restrict generic manufacturers from producing identical formulations but may not prevent substitution with different delivery systems.
5. Are method-of-use claims significant in this patent?
Yes. They extend protection to specific therapeutic applications, preventing use of the formulation for declared indications.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 9,750,754. Retrieved from https://USPTO.gov
[2] European Patent Office. (2022). Patent family related to US 9,750,754.
[3] PatentScope. (2023). Patent citations and related documents for US 9,750,754.
[4] Johnson, L. (2022). Drug formulation patent strategies. Journal of Pharmaceutical Innovation, 17(4), 335–347.
